Stage IIIA Colorectal Cancer AJCC v8 Active Not Recruiting Phase 2 Trials for TAS-102 (DB08937)

IndicationStatusPhase
DBCOND0109857 (Stage IIIA Colorectal Cancer AJCC v8)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04109924TAS-102, Irinotecan, and Bevacizumab for the Treatment of Pre-treated Metastatic or Unresectable Colorectal Cancer, the TABAsCO StudyTreatment
NCT03992456Panitumumab, Regorafenib, or TAS-102, in Treating Patients With Metastatic and/or Unresectable RAS Wild-Type Colorectal CancerTreatment